MedX Health Corp - Skin Screening and Evaluation Technology MedX Health Corp - Skin Screening and Evaluation Technology MedX Health is headquartered at Toronto, Ontario, CANADA and is an innovative medical device company focused on and is addressing skin cancer (Melanoma); it manufactures and distributes high tech medical solutions SIMSYS™ and MoleMate™ , that are hand-held devices that use patented technology utilizing light energy and its remittance to view "beneath the surface of the skin" to view suspicious moles and lesions utilizing a pain free, non-invasive method, that results in creating real-time images for physicians and dermatologists to Quickly and accurately evaluate all types of moles or lesions within seconds. MedX also manufactures and markets SIAMETRICS™ , a product designed for research and development within the field of clinical trials to accurately measure and quantify the concentrations of melanin, hemoglobin and collagen in living human skin. SIAMETRICS™ facilitates the collection and analysis of data during a clinical trial. Many cosmetic and skincare products are formulated to affect changes in three primary constituents of skin; hemoglobin, melanin and collagen concentrations and distribution. SIAMETRICS™ is based on a thorough understanding ofhow light interacts with the skin’s chromophores and uses specific wavelengths of light to analyze the skin, producing maps and data points within the hemoglobin, melanin and collagen.